We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Glycemic Response to Road Cycling in Type 1 Diabetes

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2011 by Team Type 1, Inc..
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01398826
First Posted: July 21, 2011
Last Update Posted: July 21, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Team Type 1, Inc.
July 19, 2011
July 21, 2011
July 21, 2011
May 2011
August 2011   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Glycemic Response to Road Cycling in Type 1 Diabetes
A Pilot Study Assessing the Glycemic Response and Its Relationship to Performance During Road Cycling in Elite Athletes With Type 1 Diabetes and Non-Diabetic Controls
The purpose of this study is to assess the glycemic response to cycling road races (using continuous glucose monitoring ) in elite athletes with type 1 diabetes and non-diabetic controls. The investigators will also assess the relationship between power/work during cycling (using a power meter) and the subject's glucose profile.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Professional cyclists on TeamType 1 cycling teams
Type 1 Diabetes
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
30
August 2011
August 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • ≥18 years of age
  • A1C ≤8.0% if diagnosed with type 1 DM

Exclusion Criteria:

  • If diagnosed with type 1 diabetes, has had recurrent severe hypoglycemia (greater than 2 episodes in previous 6 months requiring assistance by a third party)
  • Has any medical condition or medical history that may affect successful completion of the study and/or personal well-being (as assessed by the PI)
Sexes Eligible for Study: Male
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01398826
TT1-001
No
Not Provided
Not Provided
Juan Pablo Frias, MD, TeamType 1
Team Type 1, Inc.
Not Provided
Principal Investigator: Juan P Frias, MD Team Type 1, Inc.
Team Type 1, Inc.
July 2011